Jump to content

RET clinical trial info


Recommended Posts


Learn more about a clinical trial available for patients with non-small cell lung cancer harboring a RET alteration. Now enrolling, the Phase 1 ARROW clinical trial is testing an experimental medicine called BLU-667. The ARROW trial is open at multiple clinical sites in the United States, Europe and Asia. A travel support program is also available to qualified patients and caregivers to reimburse eligible local and long-distance travel and lodging. More information about the trial, including eligibility criteria and a list of active trial sites, is available at www.arrowtrial.com or www.clinicaltrials.gov (Identifier: NCT03037385). You can also contact the clinical trial sponsor, Blueprint Medicines, at (617)-714-6707 or studydirector@blueprintmedicines.com to be connected to a clinical trial site near you.



Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.